BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:45 PM
 | 
Oct 16, 2012
 |  BC Extra  |  Company News

Novo seeks approval of hemophilia A therapy

Novo Nordisk A/S (CSE:NVO; NYSE:NVO) submitted regulatory applications to FDA and...

Read the full 38 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >